Abstract
Cadherin-17 (CDH17) is highly expressed in gastric cancer and is thus considered to be a good target for antibody therapy. CDH17 is classified as a nonclassical cadherin, in that it is composed of seven extracellular cadherin domains. We generated anti-CDH17 monoclonal antibodies (mAbs) which recognize the extracellular domain of CDH17. Competitive assay using AGS, a gastric cancer cell line, cells revealed that five selected anti-CDH17 mAbs recognize different epitopes on CDH17. As AGS cells were shown to exhibit broad expression pattern of CDH17 by flow cytometry, we separated three clones with a low (10,000/cell), medium (50,000/cell), and high (200,000/cell) expression level, designating them as AGSlow, AGSmed, and AGShigh, respectively. The mAbs, coupled with saporin, exhibited effective cytotoxicity to AGShigh, but poor cytotoxicity to AGSlow. By contrast, the immunotoxin cocktail using the three clones D2101, D2005, and D2008, which recognize different epitopes, exhibited efficient cytotoxicity, even to the AGSlow group. The effect of the immunotoxin cocktail is synergistic, as the combination index was demonstrated to be below 1.0, as calculated by the method of Chou and Talalay using CalcuSyn software. These results su...Continue Reading
References
Dec 1, 1987·British Journal of Haematology·F E KatzP E Thorpe
Oct 1, 1994·Current Opinion in Cell Biology·B Ranscht
Jan 1, 1994·Journal of Drug Targeting·A J RowlandG A Pietersz
Oct 1, 1995·Current Opinion in Cell Biology·M Takeichi
Jun 26, 2003·Cancer Science·Masaaki TakamuraSetsuo Hirohashi
Nov 19, 2003·Biochemical and Biophysical Research Communications·Bonnie W WongS T Fan
Feb 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Lilach M FriedmanYosef Yarden
Jan 30, 2007·Analytical Chemistry·Thomas R GlassHiroshi Saiki
Mar 22, 2007·Journal of Immunological Methods·Ryoichi SaitohTakao Hamakubo
Aug 8, 2007·Trends in Biotechnology·Ton Logtenberg
Nov 14, 2007·Digestive Diseases and Sciences·Wei-Guo DongLi-Fang Fan
Jun 17, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Min-Cheng SuYung-Ming Jeng
Aug 14, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ling Xiao LiuJohn M Luk
Jan 14, 2010·Cancer Research·Ting-Chao Chou
Jun 8, 2012·Molecular BioSystems·Shota KudoKouhei Tsumoto
Jan 12, 2013·Medical Molecular Morphology·Masaaki TakamuraYutaka Aoyagi
Apr 5, 2013·PloS One·Hai-bo QiuRui-hua Xu
Apr 23, 2013·Oncogene·R A BartoloméJ I Casal
Sep 17, 2013·PloS One·Yonggang WangJohn M Luk
Dec 29, 2013·Cancer Research·Esther C W BreijPaul W H I Parren
Jan 28, 2014·PloS One·Zhaohu LinXiongwen Zhang
Feb 25, 2014·Biochemistry·Shota KudoKouhei Tsumoto
Jan 1, 2013·Tissue Barriers·Werner Baumgartner
Aug 20, 2014·Biochimica Et Biophysica Acta·Takao HamakuboHiroko Iwanari
Oct 29, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jordan B PasternackRoger W Howell
Mar 1, 2015·Molecular Cancer Therapeutics·Bart E C G de GoeijPaul W H I Parren
Sep 24, 2015·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Sabrina M EbingerMarc Schiesser
Jan 15, 2016·Cancer Cell·John Y LiSteven R Coats
Mar 11, 2016·Current Opinion in Immunology·Bart Ecg de Goeij, John M Lambert
Apr 21, 2016·Analytical Biochemistry·Osamu Kusano-AraiTakao Hamakubo
Apr 30, 2016·Human Genetics·Daeun RyuWoong-Yang Park
Jun 15, 2016·The Lancet Oncology·Anish ThomasRaffit Hassan
Sep 1, 2016·Oncotarget·Keisuke MatsusakaMasashi Fukayama